Related Experiment Video

Updated: Apr 4, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

1.1K

IDEA: Integrated Drug Expression Analysis-Integration of Gene Expression and Clinical Data for the Identification of

M H Ung1, F S Varn1, C Cheng2

  • 1Department of Genetics, Geisel School of Medicine at Dartmouth Hanover, New Hampshire, USA.

CPT: Pharmacometrics & Systems Pharmacology
|August 28, 2015
PubMed

Insights

This study introduces a new computational method, Integrated Drug Expression Analysis (IDEA), to speed up the discovery of breast cancer drugs. IDEA uses gene expression and patient survival data to identify promising drug candidates more efficiently.

Area of Science:

  • Computational biology
  • Genomics
  • Pharmacology

Background:

  • Cancer drug discovery is lengthy and complex.
  • High-throughput genomics enables in silico drug screening.
  • Accelerating preclinical drug discovery is crucial.

Purpose of the Study:

  • To develop a novel computational approach for identifying breast cancer drug candidates.
  • To accelerate the preclinical screening of potential cancer therapeutics.

Main Methods:

  • Developed a Drug Regulatory Score similarity metric for gene expression profiles.
  • Integrated time-to-event patient survival data.
  • Created the Integrated Drug Expression Analysis (IDEA) pipeline.

Main Results:

  • Successfully predicted known and novel anticancer drug candidates for breast cancer.
  • Demonstrated the utility of IDEA in identifying effective therapeutics.
  • Validated the approach using survival data as a key efficacy indicator.

Conclusions:

  • The IDEA pipeline offers a rapid method for preclinical drug candidate screening.
  • This approach can be applied to breast cancer and other diseases.
  • Patient survival data is a critical factor in evaluating drug efficacy.

More Related Videos

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.7K
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

7.1K

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
86
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.3K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
68
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
296